LAVA Therapeutics N.V. (LVTX)

LAVA Therapeutics Revenue

LAVA Therapeutics had revenue of $13.63M in the twelve months ending March 31, 2024, down -36.01% year-over-year. Revenue in the quarter ending March 31, 2024 was $7.60M with 471.24% year-over-year growth. In the year 2023, LAVA Therapeutics had annual revenue of $7.52M, a decrease of -63.54%.

• Revenue (ttm): $13.63M
• Revenue Growth: -36.01%
• P/S Ratio: 3.65
• Revenue / Employee: $368,302
• Employees: 37
• Market Cap: 49.69M USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	7.52M	-13.11M	-63.54%
Dec 31, 2022	20.63M	14.55M	239.31%
Dec 31, 2021	6.08M	1.51M	33.05%
Dec 31, 2020	4.57M	-	-
Dec 31, 2019	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.